Literature DB >> 8564267

Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats.

R P Waite1, S L Lim, C C Pang.   

Abstract

1. The effects of the potassium channel opener, pinacidil, on mean arterial pressure (MAP), mean circulatory filling pressure (MCFP), total peripheral resistance (TPR), cardiac output (CO) and resistance to venous return (Rv) were studied in rats. 2. In pentobarbitone-anaesthetized rats given mecamylamine (ganglionic blocker, 3.7 micrograms kg-1) and noradrenaline (1.5 micrograms kg-1 min-1) to suppress autonomic reflexes, pinacidil (60 and 180 micrograms kg-1 min-1), relative to the vehicle, reduced MAP and TPR in a dose-dependent manner but did not significantly alter CO, MCFP or RV. 3. Pinacidil (10-300 micrograms kg-1 min-1) caused similar increases in MCFP, an inverse index of venous compliance, and similar dose-dependent reductions in mean arterial pressure (MAP) in conscious, intact rats and rats infused with the ganglionic blocker, hexamethonium (150 micrograms kg-1 min-1). In rats with vasomotor tone elevated by the infusion of noradrenaline (1.5 micrograms kg-1 min-1), pinacidil caused markedly greater depressor responses but did not significantly alter MCFP. 4. Our results show that pinacidil is an efficacious vasodilator of arterial resistance blood vessels but has little venodilator activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564267      PMCID: PMC1908986          DOI: 10.1111/j.1476-5381.1995.tb15072.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  The relation between vascular relaxant and cardiac electrophysiological effects of pinacidil.

Authors:  M I Steinberg; P Ertel; J K Smallwood; V Wyss; K Zimmerman
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

2.  Effects of calcium antagonists on mean circulatory filling pressure in the conscious rat.

Authors:  R P Waite; C C Pang; M J Walker
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

3.  Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.

Authors:  S D Longman; J C Clapham; C Wilson; T C Hamilton
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

4.  The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques.

Authors:  J S Southerton; A H Weston; K M Bray; D T Newgreen; S G Taylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

5.  Increase by NG-nitro-L-arginine methyl ester (L-NAME) of resistance to venous return in rats.

Authors:  Y X Wang; S L Lim; C C Pang
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Effect of vasopressin antagonist and saralasin on regional blood flow following hemorrhage.

Authors:  C C Pang
Journal:  Am J Physiol       Date:  1983-11

7.  Effects of vasodilator drugs on venous tone in conscious rats.

Authors:  H M D'Oyley; R Tabrizchi; C C Pang
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

8.  In vitro studies on the mode of action of pinacidil.

Authors:  A H Weston; K M Bray; S Duty; A D McHarg; D T Newgreen; J S Southerton
Journal:  Drugs       Date:  1988       Impact factor: 9.546

9.  Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.

Authors:  N S Cook; U Quast; R P Hof; Y Baumlin; C Pally
Journal:  J Cardiovasc Pharmacol       Date:  1988-01       Impact factor: 3.105

10.  The effects of noradrenaline, B-HT 920, methoxamine, angiotensin II and vasopressin on mean circulatory filling pressure in conscious rats.

Authors:  C C Pang; R Tabrizchi
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

View more
  1 in total

1.  Effect of intermedin/adrenomedullin-2 on venous tone in conscious rats.

Authors:  Aly M Abdelrahman; Catherine C Y Pang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-31       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.